LETTER
Synthesis of 2,4,7-Triarylpyrrolo[2,3-d]pyrimidines
d]pyrimidines 2 – Compound 2a
1707
In summary, we have developed a simple synthetic strat-
egy that permits the assembly of aromatic p-systems onto
a pyrrolo[2,3-d]pyrimidine core in a programmable and
diversity-oriented format. A more detailed study of the
photophysical properties of the synthesized compounds in
various solvents and in a solid state and further variations
of oligoarylene branches at the pyrrolo[2,3-d]pyrimidine
framework are currently being carried out, and the results
will be reported in due course.
To a solution of compound 1a7 (0.42 g, 1.83 mmol) in anhyd
CH2Cl2 (5 mL) DIPEA (0.48 mL, 2.75 mmol), DMAP (0.07
g, 0.57 mmol), and di(tert-butyl)dicarbonate (0.6 g, 2.75
mmol) were added. The reaction mixture was refluxed for 80
min, CH2Cl2 was evaporated under reduced pressure, and the
residue was purified by column chromatography (eluent:
CHCl3) to give compound 2a (0.37g, 61%); mp 76–77 °C.
1H NMR (300 MHz, CDCl3): d = 1.74 (s, 9 H, CMe3), 6.89
(d, J = 4.2 Hz, 1 H, 5-H), 7.58–7.61 [m, 3 H, 3¢,4¢,5¢-H (Ph)],
7.74 (d, J = 4.2 Hz, 1 H, 6-H), 8.06–8.09 [m, 2 H, 2¢,6¢-H
(Ph)]. 13C NMR (75 MHz, CDCl3): d = 28.3, 86.0, 104.1,
116.9, 128.0, 129.2, 129.3, 131.2, 136.6, 147.3, 154.4,
156.2, 160.6. HRMS: m/z calcd for C17H16ClN3O2 [M + H]+:
330.1004; found: 330.1000.
Acknowledgment
Research Council of Lithuania is greatly acknowledged for financi-
al support (project No. MIP-65/2010).
(10) Representative Procedure for the Preparation of 2,4-
Diaryl-7-(tert-butoxycarbonyl)-7H-pyrrolo[2,3-d]-
pyrimidines 3a–c – Compound 3a
References and Notes
A solution of compound 2a (0.07 g, 0.21 mmol) in anhyd
1,4-dioxane (5 mL) was degassed with argon, and Pd(OAc)2
(2.0 mol%) and dicyclohexyl(2-biphenyl)phoshine (4.0
mol%) were added with stirring under argon. The mixture
was stirred for 10 min, then 4-ethoxyphenylboronic acid
(0.042 g, 0.25 mmol) and anhyd K3PO4 (0.11 g, 0.52 mmol)
were added. The reaction mixture was refluxed for 4 h. Then
the solvent was evaporated under reduced pressure, and H2O
(5 mL) was added to dissolve inorganic salts. The obtained
solution was extracted with CHCl3 (3 × 25 mL), the
combined organic layers were dried with Na2SO4, filtered,
and evaporated under reduced pressure to dryness. The
resulting solid was purified by column chromatography
(eluent: CHCl3) to give compound 3a (0.07 g, 79%); mp
141–141.9 °C. 1H NMR (300 MHz, CDCl3): d = 1.49 (t,
J = 6.9 Hz, 3 H, Me), 1.81 (s, 9 H, CMe3), 4.16 (q, J = 6.9
Hz, 2 H, OCH2), 6.88 (d, J = 4.2 Hz, 1 H, 5-H), 7.05 [dm,
J = 9.0 Hz, 2 H, 3¢,5¢-H (EtOC6H4)], 7.58–7.61 [m, 3 H,
3¢,4¢,5¢-H (Ph)], 7.75 (d, J = 4.2 Hz, 1 H, 6-H), 8.20 [dm,
J = 7.9 Hz, 2 H, 2¢,6¢-H (Ph)], 8.68 [dm, J = 9.0 Hz, 2 H,
2¢,6¢-H (EtOC6H4)]. 13C NMR (75 MHz, CDCl3): d = 15.1,
28.5, 63.7, 84.9, 104.4, 114.5, 115.9, 127.1, 129.0, 129.3,
130.1, 130.4, 131.4, 138.4, 148.6, 154.3, 158.2, 159.9,
161.1. HRMS: m/z calcd for C25H25N3O3 [M + H]+:
416.1969; found: 416.1962.
(1) (a) Hughes, G.; Bryce, M. R. J. Mater. Chem. 2005, 15, 94.
(b) Wong, W. Y.; Zhou, G.-J.; Yu, X.-M.; Kwok, H.-S.; Lin,
Z. Adv. Funct. Mater. 2007, 17, 315. (c) Tao, Y.; Wang, Q.;
Yang, C.; Wang, Q.; Zhang, Z.; Zou, T.; Qin, J.; Ma, D.
Angew. Chem. Int. Ed. 2008, 47, 8104.
(2) (a) Wong, K.-T.; Hung, T. S.; Lin, Y.; Wu, C.-C.; Lee, G.-
H.; Peng, S.; Chou, C. H.; Su, Y. O. Org. Lett. 2002, 4, 513.
(b) Wu, C. C.; Lin, Y. T.; Chiang, H. H.; Cho, T. Y.; Chen,
C. W.; Wong, K. T.; Liao, Y. L.; Lee, G. H.; Peng, S. M.
Appl. Phys. Lett. 2002, 81, 577. (c) Yamaguchi, Y.;
Kobayashi, S.; Wakamiya, T.; Matsubara, Y.; Yoshida, Z.
Angew. Chem. Int. Ed. 2005, 44, 7040. (d) Achelle, S.;
Ramondenc, Y.; Marsais, F.; Ple, N. Eur. J. Org. Chem.
2008, 3129. (e) Jaung, J.-Y. Dyes Pigments 2006, 71, 245.
(3) (a) Petitjean, A.; Khoury, R. G.; Kyritsakas, N.; Lehn, J.-M.
J. Am. Chem. Soc. 2004, 126, 6637. (b) Schull, G.;
Douillard, L.; Fiorini-Debuisschert, C.; Charra, F.;
Mathevet, F.; Kreher, D.; Attias, A.-J. Adv. Mater. 2006, 18,
2954.
(4) (a) Bunzli, J.-C. G.; Piguet, C. Chem. Soc. Rev. 2005, 34,
1048. (b) Diring, S.; Retailleaub, P.; Ziessel, R. Tetrahedron
Lett. 2007, 48, 8069.
(5) Seela, F.; Steker, H. Liebigs Ann. Chem. 1984, 1719.
(6) Berry, D. A.; Jung, K.-Y.; Wise, D. S.; Sercel, A. D.;
Pearson, W. H.; Mackie, H.; Randolph, J. B.; Somers, R. L.
Tetrahedron Lett. 2004, 45, 2457.
(11) Representative Procedure for the Preparation of 2,4-
Diaryl-7H-pyrrolo[2,3-d]pyrimidines 4a–c – Compound
4a
(7) Tumkevicius, S.; Dodonova, J.; Kazlauskas, K.; Masevicius,
V.; Skardziute, L.; Jursenas, S. Tetrahedron Lett. 2010, 51,
3902.
To a solution of compound 3a (0.1 g, 0.24 mmol) in a
mixture of acetone (9 mL) and H2O (2 mL) concd HCl (0.06
mL, 1.94 mmol) was added. The reaction mixture was
refluxed with stirring for 7 d, then cooled to r.t., the
precipitate was filtered off to give compound 4a (0.06g,
80%); mp 275–276 °C. 1H NMR (300 MHz, DMSO-d6):
d = 1.39 (t, J = 6.9 Hz, 3 H, Me), 4.13 (q, J = 6.9 Hz, 2 H,
OCH2), 6.90 (dd, J3 = 3.5 Hz, J4 = 1.8 Hz, 1 H, 5-H), 7.08
[dm, J = 9.0 Hz, 2 H, 3¢,5¢-H (EtOC6H4)], 7.59–7.65 [m, 4 H,
6-H, 3¢,4¢,5¢-H (Ph)], 8.31 [dm, J = 7.9 Hz, 2 H, 2¢,6¢-H
(Ph)], 8.49 [dm, J = 9.0 Hz, 2 H, 2¢,6¢-H (EtOC6H4)], 12.21
(s, 1 H, NH). 13C NMR (75 MHz, DMSO-d6): d = 15.4, 63.9,
100.9, 113.4, 114.9, 128.4, 129.3, 129.6, 129.7, 130.8,
131.7, 138.9, 154.5, 156.1, 157.0, 160.6. HRMS: m/z calcd
for C20H17N3O [M + H]+: 316.1444; found: 316.1446.
(12) Klapars, A.; Antilla, J. C.; Huang, X.; Buchwald, S. L. J. Am.
Chem. Soc. 2001, 123, 7727.
(8) (a) Mohamed, M. S.; El-Domany, R. A.; El-Hameed, R. H.
A. Acta Pharm. 2009, 59, 145. (b) Wiesner, J. B.; Ugarkar,
B. G.; Castellino, A. J.; Barankiewicz, J.; Dumas, D. P.;
Gruber, H. E.; Foster, A. C.; Erion, M. D. J. Pharm. Exp.
Ther. 1999, 289, 1669. (c) Calderwood, C. J.; Johnston, D.
N.; Munschauer, R.; Rafferty, P. Bioorg. Med. Chem. Lett.
2002, 12, 1683. (d) Altmann, E.; Missbach, M.; Green, J.;
Susa, M.; Wagenknecht, H.; Widler, L. Bioorg. Med. Chem.
Lett. 2001, 11, 853. (e) Widler, L.; Green, J.; Missbach, M.;
Susa, M.; Altmann, E. Bioorg. Med. Chem. Lett. 2001, 11,
849. (f) Gibson, C. L.; Huggan, J. K.; Kennedy, A.; Kiefer,
L.; Lee, J. K.; Suckling, C. J.; Clements, C.; Harvey, A. L.;
Hunter, W. N.; Tulloch, L. B. Org. Biomol. Chem. 2009, 7,
1829. (g) Hess, S.; Muller, C. E.; Frobenius, W.; Reith, U.;
Klotz, K.-N.; Eger, K. J. Med. Chem. 2000, 43, 4636.
(h) Naus, P.; Pohl, R.; Votruba, I.; Dzubak, P.; Haiduch, M.;
Ameral, R.; Birkus, G.; Wang, T.; Ray, A. S.; Mackman, R.;
Cihlar, T.; Hocek, M. J. Med. Chem. 2010, 53, 460.
(9) Representative Procedure for the Preparation of 4-Aryl-
7-(tert-butoxycarbonyl)-2-chloro-7H-pyrrolo[2,3-
(13) Representative Procedure for the Preparation of 2,4,7-
triaryl-7H-pirolo[2,3-d]pirimidines(5) – Compound 5a
A solution of compound 4a (0.06 g, 0.19 mmol) in anhyd
1,4-dioxane (3 mL) was degassed with argon, and CuI (1
mol%) and anhyd K3PO4 (0.07 g, 0.33 mmol) were added.
Synlett 2011, No. 12, 1705–1708 © Thieme Stuttgart · New York